EPIDAREX EXEED LIMITED

🏛️Establishedactive
SC639047 · ltd · incorporated 2019-08-16
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
not disclosed
Net worth
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 71/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: 2 insolvency-related filings on record. Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (61/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (3 active, 3 linked, 3 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
15 connected companies via shared directors
90
Filing history
39 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
67
Some moderate concerns — review flags.
Signal strength
90
Good data coverage for analysis.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (24 events)Click to expand
  1. 2026-01-06
    📄
    accounts-with-accounts-type-small
    accounts · AA
  2. 2024-12-30
    📄
    accounts-with-accounts-type-small
    accounts · AA
  3. 2023-12-20
    📄
    accounts-with-accounts-type-small
    accounts · AA
  4. 2023-01-30
    📄
    accounts-with-accounts-type-small
    accounts · AA
  5. 2022-11-23
    📄
    gazette-filings-brought-up-to-date
    gazette · DISS40
  6. 2022-11-22
    📄
    gazette-notice-compulsory
    gazette · GAZ1
  7. 2022-07-01
    📄
    memorandum-articles
    incorporation · MA
  8. 2022-07-01
    📄
    resolution
    resolution · RESOLUTIONS
  9. 2022-07-01
    📄
    capital-statement-capital-company-with-date-currency-figure
    capital · SH19
  10. 2022-07-01
    📄
    legacy
    capital · SH20
  11. 2022-07-01
    ⚠️
    legacy
    insolvency · CAP-SS
  12. 2022-07-01
    📄
    resolution
    resolution · RESOLUTIONS
  13. 2022-06-24
    📄
    capital-allotment-shares
    capital · SH01
  14. 2022-03-22
    📄
    capital-statement-capital-company-with-date-currency-figure
    capital · SH19
  15. 2022-03-22
    📄
    legacy
    capital · SH20
  16. 2022-03-22
    ⚠️
    legacy
    insolvency · CAP-SS
  17. 2022-03-22
    📄
    resolution
    resolution · RESOLUTIONS
  18. 2022-03-18
    📄
    capital-allotment-shares
    capital · SH01
  19. 2022-01-18
    📄
    accounts-with-accounts-type-small
    accounts · AA
  20. 2021-11-09
    📄
    capital-allotment-shares
    capital · SH01
  21. 2019-09-26
    FINAN, Peter Michael, Dr appointed
    director
  22. 2019-08-16
    🏢
    Company incorporated
    As EPIDAREX EXEED LIMITED
  23. 2019-08-16
    ROPER, Elizabeth Ann, Dr appointed
    director
  24. 2019-08-16
    STEINHAGEN, Henning Klaus-Willi Christian, Dr appointed
    director

Owner dependency

58/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • +Senior director age: Director aged approximately 59 — approaching natural succession window.

Succession & seller-readiness

40/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • secondaryFounder aged 58+: Senior director is approximately 59. Early succession window.

Red flags

1 high ·
2 insolvency-related filings on record
high

Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding.

Evidence: 2022-07-01: legacy; 2022-03-22: legacy

Group structure

Epidarex Capital Iii Uk, Lp is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Epidarex Capital Iii Uk, Lp
Corporate parent · holds 75-100% shares · board control
ultimate parent
EPIDAREX EXEED LIMITED
This company · SC639047

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Epidarex Capital Iii Uk, Lp
Corporate entity
75100%
75–100%board control75-100% shares · 75-100% voting · board control16/08/2019

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · EH postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
EQUILIBRIUM GREEN LIMITED
SC507607 · est 2015 · no financials extracted
10y
EQUITIX EUROPEAN INFRASTRUCTURE I EPS GP LIMITED
SC606104 · est 2018 · no financials extracted
7y
EQUITIX MA EPS GP 17 LIMITED
SC622720 · est 2019 · no financials extracted
7y
EQUITIX MA EPS GP 28 LIMITED
SC751000 · est 2022 · no financials extracted
3y
ERA FLEET COST MANAGEMENT LIMITED
SC353202 · est 2009 · no financials extracted
17y
ESTO CONSULTANCY LIMITED
SC771890 · est 2023 · no financials extracted
2y
ETIHADPRIME PRIVATE LIMITED
SC822444 · est 2024 · no financials extracted
1y
ETTRICKBURN LIMITED
SC520211 · est 2015 · no financials extracted
10y
EUROWAVE LIMITED
SC052720 · est 1973 · no financials extracted
53y
EVANS TAX AND ACCOUNTS LIMITED
SC882020 · est 2026 · no financials extracted
EVERCHARGEEV LTD
SC697199 · est 2021 · no financials extracted
4y
EXERGY3 LIMITED
SC641651 · est 2019 · no financials extracted
6y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2019-08-16
Jurisdictionscotland
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

137a George Street
Edinburgh
Scotland
EH2 4JY
Scotland

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-09-16
Last: 2025-09-02

Officers (3 active · 0 resigned)

FINAN, Peter Michael, Dr
director · ~59y · appointed 2019-09-26
View their other companies + combined net worth →
Active
ROPER, Elizabeth Ann, Dr
director · ~52y · appointed 2019-08-16
View their other companies + combined net worth →
Active
STEINHAGEN, Henning Klaus-Willi Christian, Dr
director · ~57y · appointed 2019-08-16
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (39 total)

accounts-with-accounts-type-small
accounts · AA
2026-01-06
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-09-03
accounts-with-accounts-type-small
accounts · AA
2024-12-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-09-11
accounts-with-accounts-type-small
accounts · AA
2023-12-20
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-10-04
accounts-with-accounts-type-small
accounts · AA
2023-01-30
gazette-filings-brought-up-to-date
gazette · DISS40
2022-11-23
gazette-notice-compulsory
gazette · GAZ1
2022-11-22
confirmation-statement-with-updates
confirmation-statement · CS01
2022-11-17
memorandum-articles
incorporation · MA
2022-07-01
resolution
resolution · RESOLUTIONS
2022-07-01
capital-statement-capital-company-with-date-currency-figure
capital · SH19
2022-07-01
legacy
capital · SH20
2022-07-01
legacy
insolvency · CAP-SS
2022-07-01